| Company Name: | Walgreen Company | | Ticker Symbol: | WAG | | | WWW Address: | www.walgreens.com |
| CEO: | Gregory D. Wasson | | No. of Employees: | 171,000 |
| Common Issue Type: | CS | | Business Description: | Walgreen Co. operates retail drug store and general merchandise. It is engaged in the retail sale of prescription and non-prescription drugs and general merchandise.
|
| | | Industry Information: | RETAIL - Drug Stores [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 50.11 |  0.36 | - | - | 49.67 | 50.16 | 49.56 | 5083907 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 47,478.5 | 947.5 | 1.08 | 2.42 | 0.95 | 22.5 | 2.2 | 50.50 - 28.53 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 50.11 | $ | | PE Ratio - LTM | 22.5 | |
| Market Capitalisation | 47,478.5 | mil |
| Latest Shares Outstanding | 947.5 | mil |
| Earnings pS (EPS) | 2.42 | $ |
| Dividend pS (DPS) | 0.95 | ¢ |
| Dividend Yield | 2.2 | % |
| Dividend Payout Ratio | 39 | % |
| Revenue per Employee | 418,906 | $ |
| Effective Tax Rate | 37.0 | % |
| Float | 872.3 | mil |
| Float as % of Shares Outstanding | 92.2 | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 24.40 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 30.8 | % |
| EBITDA Margin | 6.4 | % |
| Pre-Tax Profit Margin | 4.6 | % |
| Assets Turnover | 2.3 | % |
| Return on Assets (ROA) | -0.2 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -0.3 | % |
| Current Ratio | 1.4 | |
| Leverage Ratio (Assets/Equity) | 1.9 | |
| Interest Cover | 11.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.34 | |
| LT Debt/Total Capital | 21.0 | % |
| Working Capital pS | 3.60 | $ |
| Cash pS | 2.57 | $ |
| Book-Value pS | 20.02 | $ |
| Tangible Book-Value pS | 16.07 | $ |
| Cash Flow pS | 1.24 | $ |
| Free Cash Flow pS | 1.35 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.50 | |
| Price/Tangible Book Ratio | 3.12 | |
| Price/Cash Flow | 40.3 | |
| Price/Free Cash Flow | 37.2 | |
| P/E as % of Industry Group | 95.0 | % |
| P/E as % of Sector Segment | 112.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 04/09/2013 |
| Dividend Ex-Date | 05/16/2013 |
| Dividend Record Date | 05/20/2013 |
| Dividend Pay Date | 06/11/2013 |
| Dividend Amount | 275 |
| Type of Payment | Cash Payment |
| Dividend Rate | 1.10 |
| Current Dividend Yield | 2.2 |
| 5-Y Average Dividend Yield | 2.2 |
| Payout Ratio | 39.0 |
| 5-Y Average Payout Ratio | 27.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 1.0 | 101 | 52,949 | 95,157 |
| 4 Weeks | 50.50 | 47.72 | 49.27 | 1.7 | 96 | 54,860 | 932,614 |
| 13 Weeks | 50.50 | 39.74 | 41.81 | 19.9 | 109 | 61,687 | 3,762,934 |
| 26 Weeks | 50.50 | 32.67 | 33.09 | 51.4 | 128 | 64,600 | 7,881,202 |
| 52 Weeks | 50.50 | 28.53 | 31.36 | 59.8 | 126 | 73,466 | 18,072,716 |
| YTD | 50.50 | 37.06 | - | 35.4 | 116 | 63,206 | 6,130,969 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 49.72 | 49.29 | 48.18 | 41.26 | 39.60 | 1.08 | 1.35 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 4.60 | 87.9 | 2.39 |
| Income | 3.62 | 25.7 | 2.93 |
| Dividend | 23.17 | 98.9 | 21.61 |
| Capital Spending | -10.76 | NA | -5.65 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -2.3 | 0.0 | -0.8 |
| Earnings % | -5.5 | 10.7 | 0.0 |
| EPS % | -12.8 | 1.3 | -17.7 |
| EPS $ | -0.18 | 0.01 | -0.52 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 6.09 |
| Current Ratio | 1.2 |
| Quick Ratio (Acid Test) | 0.4 |
| Liquidity Ratio (Cash) | 0.15 |
| Receivables Turnover | 30.7 |
| Average Collection Period | 12 |
| Working Capital/Equity | 11.2 |
| Working Capital pS | 2.16 |
| Cash-Flow pS | 1.24 |
| Free Cash-Flow pS | 1.65 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 4.42 |
| Financial Leverage Ratio (Assets/Equity) | 1.8 |
| Debt Ratio | 45.5 |
| Total Debt/Equity (Gearing Ratio) | 0.30 |
| LT Debt/Equity | 0.22 |
| LT Debt/Capital Invested | 29.2 |
| LT Debt/Total Liabilities | 26.8 |
| Interest Cover | 15.2 |
| Interest/Capital Invested | 0.36 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 9.76 |
| Tobin's Q Ratio | 1.42 |
| Current P/E Ratio - LTM | 22.50 |
| Enterprise Value (EV)/EBITDA | 13.26 |
| Enterprise Value (EV)/Free Cash Flow | 75.62 |
| Dividend Yield | 2.2 |
| Price/Tangible Book Ratio - LTM | 3.12 |
| Price/Book Ratio - LTM | 2.50 |
| Price/Cash Flow Ratio | 40.3 |
| Price/Free Cash Flow Ratio - LTM | 37.2 |
| Price/Sales Ratio | 0.67 |
| P/E Ratio (1 month ago) - LTM | 22.1 |
| P/E Ratio (26 weeks ago) - LTM | 13.7 |
| P/E Ratio (52 weeks ago) - LTM | 10.6 |
| 5-Y High P/E Ratio | 22.2 |
| 5-Y Low P/E Ratio | 9.2 |
| 5-Y Average P/E Ratio | 14.6 |
| Current P/E Ratio as % of 5-Y Average P/E | 154 |
| P/E as % of Industry Group | 95.0 |
| P/E as % of Sector Segment | 112.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 4.31 |
| Current Liabilities pS | 9.24 |
| Tangible Book Value pS - LTM | 16.07 |
| Book Value pS - LTM | 20.02 |
| Capital Invested pS | 23.55 |
| Cash pS - LTM | 2.57 |
| Cash Flow pS - LTM | 1.24 |
| Free Cash Flow pS - LTM | 1.35 |
| Earnings pS (EPS) | 2.42 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 2.17 |
| Free Cash Flow Margin 5YEAR AVG | 1.65 |
| Net Profit Margin | 0.0 |
| Net Profit Margin - 5YEAR AVRG. | 0.6 |
| Equity Productivity | 3.93 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 2.9 |
| Capital Invested Productivity | 3.21 |
| Return on Capital Invested (ROCI) | 0.0 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 2.5 |
| Assets Productivity | 2.40 |
| Return on Assets (ROA) | 0.0 |
| Return on Assets (ROA) - 5YEAR AVRG. | 1.6 |
| Gross Profit Margin | 30.8 |
| Gross Profit Margin - 5YEAR AVRG. | 29.7 |
| EBITDA Margin - LTM | 6.4 |
| EBIT Margin - LTM | 4.8 |
| Pre-Tax Profit Margin | 4.7 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 5.3 |
| Effective Tax Rate | 37.0 |
| Effective Tax Rate - 5YEAR AVRG. | 37.1 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 65 |
| Revenue per Employee | 418,906 |
| Net Income per Employee | |
| Average Collection Period | 11 |
| Receivables Turnover | 30.7 |
| Day's Inventory Turnover Ratio | 54 |
| Inventory Turnover | 6.6 |
| Inventory/Sales | 9.8 |
| Accounts Payble/Sales | 6.12 |
| Assets/Revenue | 0.42 |
| Net Working Capital Turnover | 35.15 |
| Fixed Assets Turnover | 3.16 |
| Total Assets Turnover | 2.4 |
| Revenue per $ Cash | 55.23 |
| Revenue per $ Plant | 5.95 |
| Revenue per $ Common Equity | 3.93 |
| Revenue per $ Capital Invested | 3.21 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 23.6 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 22.9 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |
